Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT001 Dose-Ranging Study in Asthma
NCT02433834Phase 2Completed
- Sponsor
- Pearl Therapeutics
- Start
- May 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glycopyrronium in asthma, sponsored by Pearl Therapeutics. Started May 2015; status: completed.
02
Drugs
glycopyrronium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02433834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02433834.